SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-16-011576
Filing Date
2016-08-08
Accepted
2016-08-08 15:40:19
Documents
51
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q f10q_080816p.htm 10-Q 567038
2 EXHIBIT 10.1 exh_101.htm EX-10.1 948
3 EXHIBIT 10.2 exh_102.htm EX-10.2 236996
4 EXHIBIT 10.3 exh_103.htm EX-10.3 1377
5 EXHIBIT 31.1 exh_311.htm EX-31.1 9820
6 EXHIBIT 31.2 exh_312.htm EX-31.2 9859
7 EXHIBIT 32.1 exh_321.htm EX-32.1 3913
8 EXHIBIT 32.2 exh_322.htm EX-32.2 3558
15 GRAPHIC exh101_1.jpg GRAPHIC 183808
16 GRAPHIC exh101_2.jpg GRAPHIC 119962
17 GRAPHIC exh103_1.jpg GRAPHIC 183482
18 GRAPHIC exh103_2.jpg GRAPHIC 168563
19 GRAPHIC exh103_3.jpg GRAPHIC 97194
20 GRAPHIC exh102_1.jpg GRAPHIC 162125
21 GRAPHIC exh102_2.jpg GRAPHIC 117386
  Complete submission text file 0001171843-16-011576.txt   5323905

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE FILE bcrx-20160630.xml EX-101.INS 588437
10 XBRL SCHEMA FILE bcrx-20160630.xsd EX-101.SCH 44973
11 XBRL CALCULATION FILE bcrx-20160630_cal.xml EX-101.CAL 35263
12 XBRL DEFINITION FILE bcrx-20160630_def.xml EX-101.DEF 330613
13 XBRL LABEL FILE bcrx-20160630_lab.xml EX-101.LAB 317451
14 XBRL PRESENTATION FILE bcrx-20160630_pre.xml EX-101.PRE 333123
Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-23186 | Film No.: 161813997
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1